MyFinsight
Home
Blog
About
Contact
Download
Download image
Net decrease in cash
and cash...
-$3,231,370
Accounts payable and
other current...
$28,502
Stock-based compensation
$23,385
Prepaid expense and
other assets
-$16,288
Non-cash lease expense
$792
Net cash used in
operating activities
-$3,231,370
Canceled cashflow
$68,967
Net loss
-$3,300,337
Back
Back
Cash Flow
source: myfinsight.com
Inhibitor Therapeutics, Inc. (INTI)
Inhibitor Therapeutics, Inc. (INTI)